LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Clinical trial NCT03711929 · TERMINATED
Trial details
- NCT number
- NCT03711929
- Sponsor
- Santen Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-19
- Primary completion
- 2022-06-14
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.